Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Obesity × Genitourinary × Clear all

Status

Sponsor Class

OTHER 13 NIH 1 INDUSTRY 1 FED 1

Study Type

Observational 1

Sponsor

Cancer Type

Other 5 Genitourinary 1 Gastrointestinal 1 CNS 1 Breast 1

Conditions

Prostatic Neoplasms 1162 Carcinoma, Renal Cell 589 Urinary Bladder Neoplasms 368 Carcinoma, Non-Small-Cell Lung 292 Neoplasms 270 Carcinoma, Transitional Cell 233 Ovarian Neoplasms 216 Breast Neoplasms 212 Melanoma 197 Colorectal Neoplasms 196 Neoplasm Metastasis 192 Kidney Neoplasms 175 Pancreatic Neoplasms 146 Stomach Neoplasms 135 Squamous Cell Carcinoma of Head and Neck 124 Lung Neoplasms 120 Non-Muscle Invasive Bladder Neoplasms 109 Uterine Cervical Neoplasms 104 Triple Negative Breast Neoplasms 98 Head and Neck Neoplasms 97 Endometrial Neoplasms 97 Esophageal Neoplasms 94 Carcinoma, Hepatocellular 83 Sarcoma 69 Small Cell Lung Carcinoma 67 Colonic Neoplasms 45 Prostatic Neoplasms, Castration-Resistant 42 Urologic Neoplasms 41 Carcinoma 39 Liver Neoplasms 38

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01020604 2013-04-30

PROTECT-Z

AstraZeneca

GenitourinaryOther

Obesity, Prostatic Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡